Today's AAPM Symposium to Explore Radiomics
This year's symposium presented in conjunction with the American Association of Physicists in Medicine (AAPM) will describe the motivation underlying medical imaging analyses of tumor heterogeneity and response to therapy, and the role of medical imaging omics in oncology as a biomarker and the potential benefits leading to improved outcomes. Presenters Robert J. Gillies, Ph.D., and Hedvig Hricak, M.D., Ph.D., Dr. h.c., will also address the benefits and challenges of advanced and high-throughput image analysis from large databases at multiple centers.
Dr. Gillies is chair of the Department of Cancer Imaging and Metabolism, director of the Center of Excellence in Cancer Imaging and Technology, vice-chair for research in the Department of Radiology and scientific director of the Small Animal Imaging Lab (SAIL) and Image Response Assessment Team (IRAT) shared services at the Moffitt Cancer Center in Tampa, Fla. Dr. Gillies' research emphasizes the use of imaging to inform evolutionary models of carcinogenesis and response to therapy. He currently serves the National Cancer Institute as a member of the Experimental Therapeutics (NExT) special emphasis review panel and the Network Consulting Team for the Early Detection Research Network (EDRN). Dr. Gillies also serves the U.S. Department of Defense as a member of the integration panel for the Prostate Cancer Research Program.
Dr. Hricak is chair of the Department of Radiology at Memorial Sloan-Kettering Cancer Center, a professor of radiology at Cornell University Medical College and an attending radiologist at Memorial Hospital, all in New York. She is a genitourinary imaging authority who helped develop the use of MR imaging and CT for gynecological cancers. Dr. Hricak has served as the principal investigator of a National Institutes of Health (NIH)-funded study on the use of MR imaging and MR spectroscopy for risk assessment in prostate cancer patients. She also has co-directed an NIH-funded program that trains young scientists and physicians in oncologic molecular imaging. Dr. Hricak served as RSNA president in 2010.